[ad_1] HERZLIYA, Israel and CALGARY, Alberta, Oct. 9, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to […]
Tag: Biotechnology
Global Single-cell Technologies Market Poised for Explosive Growth
[ad_1] “The Market is growing rapidly, driven by its potential to transform healthcare by enabling personalized treatment and targeted therapies. With increasing investment and innovation, this market is expected to revolutionize the way diseases are […]
ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine
[ad_1] Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Attacks MINNEAPOLIS, Oct. 9, 2024 /PRNewswire/ — ShiraTronics, a clinical-stage medical device company […]
Cure® Mosquito-Borne Diseases Report Reveals Critical Disconnect Between Experts vs. Physicians and the Public
[ad_1] First-of-its-kind survey shows primary care physicians and public have low awareness, low concerns despite global surge in life-threatening mosquito-borne diseases lacking effective therapies or vaccines NEW YORK, Oct. 9, 2024 /PRNewswire/ — Cure®, a healthcare […]
Antag Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Lead Molecule, AT-7687
[ad_1] COPENHAGEN, Denmark, Oct. 9, 2024 /PRNewswire/ — Antag Therapeutics, a leading biopharmaceutical company focused on targeting the Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor to pioneer novel treatments for obesity, today announced that the U.S. Food […]
